QuiVad

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on August 11, 2026.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 8.43% on August 19, 2021. The shaded band is the year shown above.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.30%newAugust 11, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

History of disclosures

437 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 18, 2021Citadel Advisors LLC1.11%still open
August 18, 2021Consonance Capital Management LP1.07%still open
August 17, 2021Arrowstreet Capital Limited Partnership1.24%still open
August 17, 2021Consonance Capital Management LP1.17%still open
August 17, 2021Capital Fund Management SA0.60%still open
August 16, 2021Consonance Capital Management LP1.24%still open
August 12, 2021Citadel Advisors LLC1.08%still open
August 11, 2021Citadel Advisors LLC1.15%still open
August 11, 2021PDT Partners LLC0.81%still open
August 10, 2021Arrowstreet Capital Limited Partnership1.11%still open
August 10, 2021Citadel Advisors LLC1.04%still open
August 9, 2021PDT Partners LLC0.73%still open
August 6, 2021Marshall Wace LLP0.99%still open
August 4, 2021Mangrove Partners0.84%still open
August 4, 2021PDT Partners LLC0.60%still open
August 2, 2021Adage Capital Management LP1.32%still open
July 30, 2021Adage Capital Management LP1.27%still open
July 30, 2021Citadel Advisors LLC0.91%still open
July 30, 2021Capital Fund Management SA0.51%still open
July 30, 2021PDT Partners LLC0.50%still open
July 29, 2021Adage Capital Management LP1.15%still open
July 29, 2021Citadel Advisors LLC1.03%still open
July 29, 2021Arrowstreet Capital Limited Partnership1.01%still open
July 29, 2021Capital Fund Management SA0.00%still open
July 29, 2021Hrteu Limited0.00%still open
July 28, 2021Marshall Wace LLP1.06%still open
July 28, 2021Citadel Advisors LLC0.97%still open
July 28, 2021Adage Capital Management LP0.95%still open
July 28, 2021Capital Fund Management SA0.54%still open
July 27, 2021Citadel Advisors LLC1.10%still open
July 23, 2021Citadel Advisors LLC1.01%still open
July 23, 2021Worldquant LLC0.00%still open
July 22, 2021Marshall Wace LLP1.13%still open
July 22, 2021Citadel Advisors LLC0.99%still open
July 22, 2021Worldquant LLC0.53%still open
July 21, 2021Marshall Wace LLP1.07%still open
July 21, 2021Citadel Advisors LLC1.00%still open
July 21, 2021Arrowstreet Capital Limited Partnership0.90%still open
July 21, 2021Worldquant LLC0.68%still open
July 21, 2021HRTEU Limited0.54%still open
July 21, 2021Capital Fund Management SA0.00%still open
July 20, 2021Consonance Capital Management LP1.41%July 20, 2021
July 20, 2021Citadel Advisors LLC0.96%still open
July 20, 2021Marshall Wace LLP0.94%still open
July 20, 2021Worldquant LLC0.75%still open
July 20, 2021Capital Fund Management SA0.50%still open
July 19, 2021Consonance Capital Management LP1.21%still open
July 19, 2021Marshall Wace LLP0.83%still open
July 19, 2021Capital Fund Management SA0.00%still open
July 16, 2021Consonance Capital Management LP0.91%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/oncopeptides-ab?page=7